Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis
AustriaStudy on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis
GermanyStudy on Melphalan, Ipilimumab, and Nivolumab for Patients with Uveal Melanoma Liver Metastases
NorwayStudy on the Safety and Efficacy of a Hepatitis B Vaccine with Hepatitis B Surface Antigen (rDNA), MVA-HBVAC, and Mosaic HBcoreAg for Adults with Chronic Hepatitis B
GermanyStudy on the Effectiveness and Safety of TPST-1120 and Drug Combination for Patients with Advanced Liver Cancer
FranceStudy on Durvalumab, Cisplatin, and Gemcitabine for Patients with Extrahepatic Cholangiocarcinoma
GermanyStudy on Atezolizumab, Bevacizumab, and EXL01 for Patients with Liver Cancer Not Responding to First-Line Immunotherapy
FranceStudy on Stopping Esomeprazole in Patients with Liver Cirrhosis
GermanyStudy of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers
SpainStudy on Dapagliflozin for Patients with Decompensated Liver Cirrhosis
ItalyStudy on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases
The NetherlandsStudy on the Safety and Effectiveness of MK-2870 Alone or with Other Drugs for Patients with Colorectal, Pancreatic, and Biliary Tract Cancers
ItalyThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
